J&J Lung Cancer Treatment Extends Lives Versus AstraZeneca Drug | NYSE:JNJ
J&J Rybrevant/Lazcluze Combo Bests AstraZeneca's Tagrisso in NSCLC
Johnson & Johnson Reports 'Statistically Significant' Data From Trial of Rybrevant, Lazcluze Combination to Treat Lung Cancer
Asher Bio Announces Clinical Supply Agreement With AstraZeneca To Enable Evaluation Of Etakafusp Alfa In Combination With Rilvegostomig In A Global Phase 1b/2 Study In Non-Small Cell Lung Cancer
Berenberg Maintains AstraZeneca's Rating on Promising 2025 Pipeline
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development
Vaccine Stocks Gain Amid Uptick in Flu, COVID-19, RSV
AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell?
SA Asks: Which Biotechs Are Most Likely to Be Acquired Near-term?
AstraZeneca PLC Stock Flat Friday
阿斯利康(AZN.US)PD-1/TIGIT双抗启动III期临床
阿斯利康(AZN.US)“奥希替尼”在中国获批新适应症
Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million
VKTX Stock Loses More Than 20% in Six Months: Should You Buy the Dip?
Reported Wednesday, HUTCHMED And AstraZeneca's ORPATHYS-TAGRISSO Therapy Advances In China With Priority NDA Status For MET-Amplified Lung Cancer
Takeda-backed Ascentage Pharma Files for $100M IPO
大摩:个体化癌症疫苗和ADC将成为2025年肿瘤治疗行业主要催化剂
Is AstraZeneca PLC (AZN) Among the U.K. Dividend Aristocrats for 2024?
Here Are Morgan Stanley's Key Oncology Catalysts for 2025
Daiichi Sankyo Gets Japanese Approval for Datroway